Earnings Call · Q4 FY2025·2025-07-31

Q4 25EPS +2.82%·Rev n/aQ3 25EPS +0.42%·Rev n/aQ2 25EPS +5.19%·Rev n/aQ1 25EPS +7.84%·Rev n/a⚠ consensus missing

RESMED INC RMD

Sallilyn Schwartz — Head of Investor Relations

Michael J. Farrell — Chief Executive Officer

Brett A. Sandercock — Chief Financial Officer

+2.7%1d on move date+4.3% vs SPY3d+4.8%5d+3.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RMD calls or request research access.

More RMD calls Browse calls Request research access